BS
Barry J. Simon (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in ImmunityBio, Inc. (IBRX). The largest single filing was $1.7M of IBRX (165,000 sh × $10.25, as filed), executed Feb 23. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$4.3M
shares × price, as filed
Last traded
Oct 5
Filed Oct 6
Median ADV $90.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
IBRX
ImmunityBio, Inc.
IBRX · 0 buys · 6 sells
6 filings
Recent filings
IBRXSALE
ImmunityBio, Inc.
View filing →
$269K25,000 sh × $10.75
Exec Oct 5
Filed Oct 6 · 6:06 PM ET IBRXSALE ImmunityBio, Inc. View filing → $197K
25,000 sh × $7.88
Exec Jun 24
Filed Jun 26 · 5:30 PM ET IBRXSALE ImmunityBio, Inc. View filing → $165K
23,033 sh × $7.18
Exec Jun 4
Filed Jun 5 · 5:30 PM ET IBRXSALE ImmunityBio, Inc. View filing → $901K
75,000 sh × $12.01
Exec Feb 24
Filed Feb 26 · 5:30 PM ET IBRXSALE ImmunityBio, Inc. View filing → $1.7M
165,000 sh × $10.25
Exec Feb 23
Filed Feb 24 · 5:30 PM ET IBRXSALE ImmunityBio, Inc. View filing → $1.1M
151,967 sh across 2 lots
Exec Jan 20
Filed Jan 21 · 5:30 PM ET